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Cigarette smoke exposure redirects 
Staphylococcus aureus to a 
virulence profile associated with 
persistent infection
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Cristina prat1,2 & Maisem Laabei  1,5
Tobacco smoking represents the leading preventable cause of death worldwide. Smoking is a 
recognised risk factor for several pathologies and is detrimental to host immune surveillance and 
defence. However, the impact of smoking on microbial residents of the nasopharyngeal cavity, in 
contact with cigarette smoke (CS), is lacking. Staphylococcus aureus is a major human pathogen that 
colonises the human nasopharynx and causes a wide range of infections. We investigated the impact of 
CS on specific virulence phenotypes important in S aureus pathogenesis. We observed strain-dependent 
differences following exposure to CS, namely growth inhibition, augmented biofilm formation, 
increased invasion of, and persistence within, bronchial alveolar epithelial cells. Additionally, we 
confirm the critical role of a functional accessory gene regulator (Agr) system in mediating increased 
biofilm development and host cell invasion and persistence following CS exposure. Furthermore, CS 
exposure resulted in reduced toxin production. Importantly, exposure of S aureus to Cs accelerated 
the frequency of mutations and resulted in a significant increase in gentamicin-resistant small colony 
variant (SCV) formation. Mutational analysis revealed that CS induced SCVs emerge via the SOS 
response DNA mutagenic repair system. Taken together, our results suggest that CS redirects certain S 
aureus strains to a virulence profile associated with persistence.
The tobacco epidemic is best portrayed in the approximately six million people that died as a result of cigarette 
smoking in 2010 alone1. Smoking is responsible for 90% of lung cancers2, is associated with 50% of cardiovascular 
diseases3 and is directly correlated with the development of chronic obstructive pulmonary disease4. Critically, 
smoking increases the risk for several infectious diseases5,6, most notably in the manifestation of invasive pneu-
mococcal infection7. Recently, cigarette smoke (CS) condensate has been shown to significantly increase the 
biofilm forming capacity of Streptococcus pneumoniae, potentially augmenting pneumococcal persistence and 
resistance to antibiotics8. Smoking is also strongly associated with periodontal disease9–11, typically resulting from 
oral immune dysfunction, chronic inflammation and destruction of the periodontal tissue12. New studies have 
illustrated that CS exposure augments biofilm formation in several periodontal pathogens in vitro13, thus provid-
ing a molecular explanation for the observed clinical features.
The mechanisms behind increased susceptibility to infections as a result of cigarette smoking is not fully 
understood, but past studies have largely attributed this to host immune dysregulation14–16. CS can impair nor-
mal neutrophil cell function, decreasing phagocytic killing17 and chemotaxis18, and induce overproduction 
of pro-inflammatory mediators, reactive oxygen species and enzymes, resulting in extensive cellular damage 
and immune dysfunction19. Additionally, in vitro studies have shown that CS attenuates cellular responses to 
pathogen associated molecular patterns (PAMPs) leading to immunosuppression and chronic microbial colo-
nisation20. Moreover, CS compromises the integrity of the respiratory epithelium increasing permeability and 
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inhibiting normal mucociliary movement resulting in decreased microbial clearance21. The net effect of CS on 
normal immune homeostasis permits increased susceptibility to infection by opportunistic pathogens such as 
Staphylococcus aureus.
S aureus is a member of the nasal microflora in 30–60% of people22,23. This opportunistic pathogen possesses 
a sophisticated arsenal of virulence factors permitting a suite of infections ranging in severity from superficial 
skin infections to life-threatening pneumonia or endocarditis24. Treatment of S aureus infection has been made 
more complicated by the presence of antibiotic resistant lineages such as methicillin-resistant S aureus (MRSA)25. 
Historically, MRSA infections were limited to immunocompromised healthcare- associated patients. Presently, 
there is a growing concern regarding the emergence of community-acquired (CA-) MRSA, infections in other-
wise healthy individuals outside the healthcare setting26.
Previous work has investigated the impact of CS on MRSA virulence27–29. These studies used primarily the 
USA300 strain (ST8 clone, staphylococcal cassette chromosome mec (SCCmec) IV; CA-MRSA) and illustrated 
that CS exposure resulted in a number of altered virulence phenotypes, namely augmented biofilm formation, 
decreased phagocytic killing, increased attachment and invasion of keratinocytes and increased severity in a 
mouse pneumonia model. However, MRSA is a clonal pathogen and the net result of numerous large epidemio-
logical studies has highlighted a number of predominant clones that are responsible for the majority of the global 
prevalence of MRSA and subsequent disease burden30–32. Additionally, the variation of expression of virulence 
factors of different MRSA clones and isolates within the same clone has been documented, redefining the com-
plex virulence regulation of S aureus33–35. Finally, conflicting epidemiologically data prevents a complete under-
standing of the relationship between smoking status and prevalence of S aureus36–39. Therefore, our aim was to 
assess the impact of CS on specific virulence phenotypes in a number of diverse genome-sequenced reference S 
aureus strains and to investigate any clone-specific heightened virulence as a result of CS exposure.
Materials and Methods
Bacterial strains and culture conditions. S aureus strains used in this study represent genome-sequenced 
reference strains from clonally distinct, clinically significant lineages (Table 1). All strains were routinely stored 
at −80 °C in 15% glycerol/broth stocks until required. S aureus strains were streaked onto tryptic soy agar (TSA), 
incubated for 18 h at 37 °C, and single colonies transferred to 2 mL of tryptic soy broth (TSB) in 12 mL plastic 
sterile tubes and propagated in a shaking incubator at 175 rpm for 24 h at 37 °C. 1 × 106 CFU of overnight culture 
was used to subculture into TSB or 50% CS-TSB. For transposon mutants40 erythromycin (5 µg mL−1) was added 
to the growth medium in overnight cultures but omitted in subsequent subculture.
Cigarette smoke extraction. Cigarette smoke (CS) extraction protocol was optimised based on previous 
extraction procedures investigating the effect of CS on both eukaryotic and bacterial cell physiology27,28,41. A 
60-mL syringe (Becton Dickinson) fitted with a polycarbonate stopcock 4-way male luer lock (Cole-Parmer), was 
filled with 10 mL TSB, and connected to one Marlborough cigarette (9–10 mg Tar; 0.7–0.8 mg nicotine). 50 mL 
of cigarette smoke was aspirated over 5 s, agitated for 15 s and slowly expelled. This process was repeated 8 times 
(to approximately 1 cm remaining of cigarette). The absorbance (600 nm) of each batch was documented and nor-
malised to 0.35 to ensure consistency between experiments. This 10 mL CS TSB medium (CS-TSB) was defined 
as 100% CS-TSB. The CS-TSB broth was filtered through a 0.22-µm membrane (Millipore, PVDF low-protein 
binding membrane) and used immediately. Nicotine and acrolein (Sigma) were added to S aureus cultures grown 
in TSB at various concentrations to assess their impact on SCV emergence.
S aureus growth analysis in TSB and CS-TSB. 24 h cultures of S aureus strains were normalised to 
OD600nm = 1, diluted 1:10 in TSB and 2 µL (1 × 105 CFU) was used to inoculate 200 µL of TSB or 25%, 50% or 75% 
CS-TSB medium in a 96 well Costar plate. OD600nm readings were taken every 15 min for 18 h using a Varioskan 
flash multimode reader (Thermo Scientific). Growth curves are graphed as the median of two independent exper-
iments done in triplicate.
Biofilm formation. Semi-quantitative measurements of biofilm formation on 96-well, round-bottom, poly-
styrene plates (Costar) was determined based on the classical, crystal violet method of Ziebuhr et al.42. 18 h bac-
terial cultures grown in TSB were diluted 1:40 into 100 µL TSB containing 0.5% glucose with varying percentages 
of CS TSB media (0–50%). Perimeter wells of the 96-well plate were filled with sterile H2O and plates were placed 
in a separate plastic container inside a 37 °C incubator and grown for 24 h under static conditions. Following 24 h 
growth, plates were washed vigorously five times in PBS, dried and stained with 150 μL of 1% crystal violet for 
30 min at room temperature. Following five washes of PBS, wells were re-suspended in 200 μL of 7% acetic acid, 
and optical density at 595 nm was measured using a Varioskan flash multimode reader. Experiments were done 
using three technical repeats from four independent experiments.
Vesicle Lysis Test – Agr activity. Strains were grown as described in culture conditions. Culture superna-
tants were centrifuged for 10 min at 20,000 × g and stored at −20 °C until further use. Phospholipid vesicles were 
prepared and the Vesicle Lysis Test to determine Agr activity was used as described previously43. Briefly, harvested 
cell-free supernatant were incubated in a 1:1 ratio with purified vesicles for 30 min. Fluorescent intensity was 
measured at excitation and emission wavelengths of 485 and 520 nm respectively using a Varioskan flash multi-
mode reader. Positive and negative controls used consisted of vesicles with 0.1% triton X-100 and HEPES buffer 
respectively. Normalised fluorescence was achieved using the equation (Ft–F0)/(Fm/F0) where Ft is the average 
fluorescence value at a specific time point, F0 is the minimum and Fm is the maximum fluorescence value in that 
particular experiment as described previously43. Experiments were done in triplicate and repeated three times.
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Bronchial epithelial cell culture and cytotoxicity assay. Culture supernatant was prepared accord-
ing to methods for Agr activity analysis. Type II-like bronchial epithelial cell line A549 (ATCC CCL-185) was 
cultured in Roswell Park Memorial Institute (RPMI; Biowest) medium with L-glutamine, supplemented with 
foetal bovine serum (FBS; 10%), 1% HEPES, 1% antibiotic-antimycotic solution and 0.005 M β-mercaptoethanol 
(Complete Medium (CM)) at 37 °C and 5% CO2. Epithelial cells were routinely cultured in T75 flasks (Delta 
Surface, Nunc) to approximately 90% confluency, liberated with trypsin-EDTA, and resuspended in CM. Cells 
were prepared at 5 × 105 cells mL−1 and 75 µL were added per well. 75 µL of culture supernatant (diluted to 50% 
using TSB) was added, mixed and incubated for 20 min at 37 °C. Cytotoxicity was determined by the by release of 
lactate dehydrogenase (LDH) using the CytoTox 96 non-reactive cytotoxicity as per manufacturers’ instructions 
(Promega). Cytotoxicity assays were done in duplicate and repeated three times. To investigate the reversible 
nature of CS-mediated down regulation of toxicity, JE2 was grown for 16 h in either 0% or 50% CS-TSB in dupli-
cate, supernatant harvested and cytotoxicity measured as above. Stationary phase cell pellets were washed three 
times in PBS and either resuspended in 0% CS-TSB or 50% CS-TSB and grown for 16 h and cytotoxicity measured 
at different time points.
A549 cell invasion and persistence assay. Cells were added at approximately 2.5 × 105 cells per well 
and incubated at 37 °C and 5% for 18 h, where cells were greater than 95% confluent. For invasion assay, wells 
were washed three times in PBS and 495 µL of media lacking antibiotic-antimycotic (CM-) was added 2 h 
prior to invasion. Bacterial strains grown in TSB for 18 h were sub-cultured 1:100 on the day of the experi-
ment in either TSB or 50% CS-TSB, and grown to mid-exponential phase of growth (optical density of 0.5–0.6 
OD600nm)). Bacterial cells were washed twice in PBS and normalised to OD600 of 0.3. 5 µL of washed bacteria 
were added to wells in duplicate and allowed to invade for 1 h. Bacterial suspensions were removed, wells 
washed five times in PBS and replaced with media containing 200 µg mL−1 gentamycin and 20 µg mL−1 lys-
ostaphin for 1 h. In experiments using TW20, 100 µg mL−1 lysostaphin was used. For 2 h invasion, wells were 
washed five times in PBS, cells lysed with 0.2% triton X-100 and CFU enumerated through serial dilution and 
plating onto TSA plates and incubated at 37 °C for 24 h. For 24 h invasion, wells were left for a further 23 h in 
gentamycin/lysostaphin media and invasion enumerated as above for 2 h invasion. Invasion was calculated 
as the percentage of surviving cells from t (0) to t (2) or t (24). Invasion experiments were done in duplicate 
and repeated three times.
Alpha haemolysin detection. Culture conditions and supernatant harvesting were performed as per Agr 
activity analysis. Supernatant proteins were precipitated using trichloroacetic acid, subjected to SDS-PAGE and 
Strain Description Reference
JKD6159 CA-MRSA; Type IV SCCmec; CC93; highly virulent in mouse model of skin infection; dominant Australian clone
81
MW2 CA-MRSA; Type IV SCCmec; CC1 (USA400); associated with skin and soft tissue infections; predominantly found in America
82
JE2 USA300 (CA-MRSA; Type IV SCCmec; CC8 (USA300); associated with skin and soft-tissue infections; dominant American clone) lacking plasmids p01 and p03, wild type strain of the NTML
55
EMRSA-15 HA/CA-MRSA; Type IV SCCmec; CC22; associated with a wide range of infections; globally disseminated, high prevalence in Europe
83
TW20 HA-MRSA; Type III SCCmec; CC239; associated with a wide range of infections; globally disseminated, high prevalence in Asia
84
MRSA252 HA-MRSA; Type II SCCmec; CC30; associate with haematogenous infection, bacteraemia, endocarditis, osteomyelitis; historically globally disseminated
85
SH1000 MSSA, laboratory strain, 8325-4 with a repaired rsbU gene; SigB positive 86
SH1000 katA::Tn Catalase mutant of strain SH1000 40
SH1000 ΔkatAΔahpC Catalase and alkyl hydroperoxidase reductase mutant of strain SH1000 51
SH331 SH1000 rex::Tn; 40
SH445 SH1000 umuC::Tn; 40
SH805 SH1000 recA::Tn; 40
SH1012 SH1000 rexB::Tn; 40
SH1866 SH1000 dinB::Tn; 40
SCV13 SH1000 derived GenR SCV with auxotrophy for menadione isolated following growth in 50% CS This study
Newman (ANG112) MSSA, laboratory strain isolated from human infection 87
Newman ΔtagO (ANG260) Wall teichoic acid mutant of strain Newman 88
NE95 JE2 Tn::agrB; accessory gene regulator B mutant 55
NE186 JE2 Tn::fnbA; fibronectin binding protein A mutant 55
NE1354 JE2 Tn::hla; alpha haemolysin mutant 55
NE1787 JE2 Tn::srtA; sortase A mutant 55
Table 1. List of strains used in this study. Abbreviations: CA-MRSA, community-associated MRSA; CC, clonal 
complex; NTML, Nebraska Transposon Mutant Library; SCCmec, Staphylococcal cassette chromosome mec.
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separated proteins blotted onto nitrocellulose membrane as described previously44. Membranes were incubated 
with rabbit anti-staphylococcal alpha toxin antibody (1:5000 dilution; Sigma) and primary antibodies detected 
with horseradish peroxidase-coupled protein G (1:1000; Invitrogen. Immunoblost were developed by using the 
Opti-4CN detection kit (Bio-Rad).
Small colony variant formation. Small colony variant (SCV) formation was examined as described by 
Edwards et al.45. Briefly, CFU counts were determined following growth on TSA with or without gentamicin 
(2 µg mL−1). SCVs are gentamycin resistant due to their low membrane potential and consequently lack of amino-
glycoside uptake46. SCVs were defined as gentamicin-resistant (MIC > 2 µg ml−1) bacteria that produced small, 
slow-growing, non-pigmented or weakly pigmented colonies on TSA. SCV stability was classified as previously 
described45. Briefly, SCV stability was scored as follows: a single SCV colony was streaked onto TSA without 
antibiotics and incubated for 48 h. If all colonies remained as SCV it was classed as stable, if there was a mixture of 
SCV and WT colonies it was scored as partial and if all colonies reverted back to WT levels it was scored as unsta-
ble. To investigate the role of reactive oxygen species (ROS) as a trigger for SCV formation, the ROS inhibitor 
N-acetyl-L-cysteine (NAC; Sigma) was added at a final concentration of 12.5 mM. For complementation of stable 
SCV (SCV13), menadione (Sigma) was added to the media at a final concentration of 1 µg ml−1. Results represent 
the mean ± standard deviation (SD) of five separate experiments.
Mutation frequency analysis. 1 × 106 CFU of stationary phase cultures were used to inoculate TSB and 
CS-TSB (25% and 50%) grown with shaking (175 rpm) for 16 h and 37 °C. Total CFU counts were determined 
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Figure 1. Growth curves of CA- and HA-MRSA S aureus strains grown in differing concentrations of CS-
TSB. (A) JKD6159 (CA-MRSA), (B) MW2 (CA-MRSA), (C) JE2 (CA-MRSA), (D) JE2 agrB::Tn, (E) EMRSA-
15 (HA/CA-MRSA), (F) TW20 (HA-MRSA), and (G) MRSA252 (HA-MRSA) grown with starting inocula 
of 1 × 105 CFU, in 0% CS-TSB (black) or 25% CS-TSB (red), 50% CS-TSB (blue) or 75% CS-TSB (grey) for 
18 h at 37 °C with measurements every 15 min (OD600 nm). Graphs represent the mean of two independent 
experiments done in triplicate.
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following plating on TSA agar. To determine the number of drug resistant bacteria, cultures were plated onto TSA 
containing rifampicin (100 µg mL−1) and enumerated following incubation at 37 °C for 24 h. The incidence of 
resistance was calculated by dividing the number of resistant bacteria by total number of viable bacteria. Results 
represent the mean ± SD of five separate experiments.
Whole genome sequencing. DNA was extracted from wild-type SH1000 and CS-derived SCV (SCV13) 
using the QIAamp DNA Mini Kit (Qiagen) according to manufacturers’ instructions with a pre-lysis step involv-
ing lysostaphin (0.2 mg mL−1; AMBI products). Purified DNA was sequenced at the Wellcome Trust Centre for 
Human Genetics, Oxford, on the Illumina (San Diego California, USA) HiSeq 400 platform, with 150 base-pair, 
paired-end reads. We used Stampy v1.0.2247 to map reads to a reference genome (MRSA252, NC_002952). We 
used Cortex48 for de novo assembly of genomes and identification of single nucleotide polymorphisms (SNPs) and 
short sequence insertion or deletion (indels). Quality filters were applied as previously described49.
Statistical analysis. For experiments involving a comparison of the impact of 0% or 50% CS-TSB on viru-
lence phenotype (Biofilm (Fig. 3A), Agr activity (Fig. 3B), Cytotoxicity (Fig. 4A), invasion (Fig. 5A,B), SCV and 
mutational frequency (Fig. 6A,B,F,G), SCV frequency over time and SCV stability (Fig. 7A,C) a two-way ANOVA 
with Bonferroni’s multiple comparison test was employed. For determining the impact of specific mutants in 
CS-mediated biofilm augmentation (Fig. 3C), the effect on toxicity after eliminating CS exposure (Fig. 4B), SCV 
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Figure 2. Growth dynamics of laboratory and mutant S aureus strains grown in differing concentrations of CS-
TSB. (A) SH1000 (MSSA), (B) SH1000ΔkatAΔahpC, (C) SH1000 katA::Tn, (D) Newman, (E) NewmanΔtagO, 
(F) JE2 and (G) MRSA252 grown with 6.25 mM NAC in the presence or absence of 75% CS-TSB. Starting 
inocula of 1 × 105 CFU grown for 18 h at 37 °C with measurements every 15 min (OD600 nm). Graphs represent 
the mean of two independent experiments done in triplicate.
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haemolysis (Fig. 6E) and the impact of N-acetyl-L-cysteine (NAC) on SCV emergence (Fig. 7B) one-way ANOVA 
with Dunnett’s multiple comparison test was used.
Results
CA-MRSA strains appear more resistant to reactive oxygen species (ROS) present in CS-TSB 
than HA-MRSA or laboratory strains. Cigarette smoke contains over 4,800 compounds, some of which 
have growth inhibitory properties50. To understand at which concentration CS-TSB inhibits S aureus growth, we 
assayed a range of concentrations (0%, 25%, 50% and 75%). Interestingly we observed that S aureus CA-MRSA 
strains (JKD6159, MW2 and JE2 (USA300); Fig. 1A–C) are better able to survive and replicate within CS-TSB 
than HA-MRSA (EMRSA-15; CA/HA MRSA strain, TW20 and MRSA252; Fig. 1E–G) and lab strains (SH1000 
and Newman; Fig. 2A,D). Inactivation of the global virulence regulator, the accessory gene regulator (Agr), had 
no impact on growth in CS-TSB compared to WT (Fig. 1D; strain JE2 agrB::Tn). S aureus possess detoxifying 
enzymes such as catalase (katA) and alkyl hydroperoxide reductase C (ahpC)51. In an effort to examine S aureus 
genes required to grow in CS-TSB we exposed SH1000 WT and katA/ahpC double mutant or katA mutant to 
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Figure 3. CS increases biofilm formation in a strain and Agr-dependent fashion. (A) Biofilm formation was 
evaluated using 6 genome sequenced strains following growth in 0% CS-TSB or 50% CS-TSB with 1% glucose 
for 24 h in polysterene 96 well plates. (B) Agr activity was evaluated using the vesicle lysis test, incubating self-
quenched vesicles with either 10% supernatant (JKD6159, MW2, JE2 and EMRSA-15) or 100% supernatant 
from 18 h bacterial cultures. (C) Biofilm formation was evaluated in WT (JE2), JE2 agrB::Tn, JE2 fnbA::Tn and 
JE2 srtA::Tn mutants grown with and without 50% CS-TSB. Graphs represent the mean ± SD and significant 
differences measured using a two-way ANOVA with Bonferroni’s multiple comparison test (A,B) or a one-
way ANOVA with Dunnett’s multiple comparison test was used (C) (*p < 0.05; **p < 0.01; ***p < 0.001; 
****p < 0.0001).
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acids (WTA) are abundant surface glycopolymers found in Gram-positive bacteria and play important functions 
in maintaining cell wall structure. Previous studies have highlighted the role of WTA in promoting intracellu-
lar survival52 whereby reactive oxygen species play a prominent role in microbial elimination53. Accordingly, 
we evaluated the role of WTA in protecting against CS-TSB. Interestingly, we observed that a WTA mutant 
(NewmanΔtagO; Fig. 2D,E) was hypersensitive to CS-TSB, suggesting a role of WTAs in mediating resistance to 
CS-TSB inhibition.
A key component of CS is reactive oxygen species (ROS), which at high concentrations are bactericidal53. To 
further confirm the role of ROS in S aureus growth inhibition at high concentrations of CS-TSB, we incubated 
CS-TSB with a ROS inhibitor, N-acetyl-L-cysteine (NAC), prior to bacterial inoculation. The addition of NAC 
reversed growth inhibition of both CA-MRSA (Fig. 2F, JE2) and HA-MRSA (Fig. 2G; MRSA252) strains to levels 
seen in 0% CS-TSB. In accordance to the results displayed in both Figs 1 and 2, we used 50% CS-TSB throughout 
our experiments as it was the highest concentration of CS with the lowest growth inhibitory properties and mir-
rored conditions used previously to evaluate CS-mediated modulation of S aureus virulence27,28.
CS promotes biofilm formation in a functional Agr-dependent fashion. Using 6 clonally distinct 
strains (Table 1) we observed a strain dependent increase in biofilm formation following growth in 50% CS-TSB 
(Fig. 3A). Of the 6 strains sampled, two strains, MRSA252 and TW20, showed no significant change in biofilm 
Figure 4. CS reduces cytolytic activity of S aureus in a reversible manner. (A) S aureus strains were grown in 0% 
CS-TSB or 50% CS-TSB for 16 h and cytolytic activity measured following incubation of bacterial supernatant 
with A549 cells and cell death determined by release of lactate dehydrogenase. (B) Alpha haemolysin detection 
by western blot of concentrated S aureus supernatant of strains either grown in the presence or absence of 50% 
CS-TSB. The alpha heamolysin mutant (JE2 hla::Tn) is used as a control. (C) Toxin production is rescued when 
CS exposure is lifted. JE2 was grown in 0% CS-TSB (black bar) or 50% CS-TSB (white bar) for 16 h and cytolytic 
activity of supernatants assessed. Cell pellets of 0% CS-TSB were washed and reintroduced into 0% CS-TSB 
and cytolytic activity assessed after 16 h (blue bar). Cell pellets of 50% CS-TSB were washed and reintroduced 
into either 50% CS-TSB (green bar) or 0% CS-TSB (red bar) and cytolytic activity assessed after 16 h. Graphs 
represent the mean ± SD and significant differences measured using a two-way ANOVA with Bonferroni’s 
multiple comparison test (A) or a one-way ANOVA with Dunnett’s multiple comparison test was used (C)
(****p < 0.0001).
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biomass, whereas JKD6159, MW2, JE2 and EMRSA-15 and all showed significantly increased biofilm formation, 
underpinning that distinct S aureus strains respond differently to CS-TSB.
Previous work by Kulkarni et al. illustrated a decrease in rnaIII expression, the effector molecule of the Agr 
system, a regulatory network central to virulence gene expression in S aureus, following exposure to CS27,54. We 
investigated the Agr activity of the above strains in the presence and absence of 50% CS-TSB (Fig. 3B). S aureus 
strains that formed significantly more biofilm in the presence of 50% CS-TSB had higher Agr activity under nor-
mal growth conditions (0% CS-TSB) and had significantly reduced Agr activity in the presence of 50% CS-TSB 
(JKD6159, MW2, JE2 and EMRSA-15) (Fig. 3A,B). In contrast, strains MRSA252 and TW20 which had no signif-
icant biofilm alteration in the presence of 50% CS-TSB, had lower Agr activity which was not affected by growth 
in 50% CS-TSB (Fig. 3A,B). Of note MRSA252 and TW20 had significantly lower Agr activity than the other 
strains, highlighted by the fact that 100% supernatant was used in Agr activity analysis compared to 10% for the 
high Agr active group of strains (Fig. 3B).
To fully confirm the mechanism behind CS-mediated increased biofilm we tested the biofilm forming capac-
ity of three mutants known to be important in this process, in the presence and absence of 50% CS-TSB: an Agr 
mutant (JE2 agrB::Tn) where the majority of cell surface proteins are repressed following activation of Agr54,55, a 
previously determined biofilm promoting surface protein, fibronectin binding protein A56, FnBPA (JE2 fnbA::Tn) 
and sortase A (JE2 srtA::Tn), an enzyme responsible for anchoring surface proteins to the cell wall57. Under 0% 
CS-TSB conditions an increase in biofilm was observed in the Agr mutant whereas a decrease was seen in mutants 
with impaired surface protein(s). Under 50% CS-TSB conditions we only saw an increase in WT strains, and not 
in mutants, highlighting the importance of an active, functional Agr system and expression of surface proteins, 
particularly FnBPA, in the augmentation of biofilm formation in S aureus in response to CS exposure (Fig. 3C).
CS reduces toxin production in a reversible manner. S aureus secretes a multitude of cytolytic toxins 
that interact with and lyse diverse host cell types58, where Agr plays a key role in upregulating toxin production in 
a growth-phase dependent fashion54. To examine the impact of CS on toxin expression we assessed cytolytic activ-
ity of S aureus supernatant following growth in the presence or absence of 50% CS-TSB using a bronchial alveolar 
epithelial (A549) cell line (Fig. 4A). Unsurprisingly, strains with high Agr activity were most toxic, (JKD6159, 
MW2, JE2 and EMRSA-15) whereas those with low Agr activity had very low levels of toxicity (MRSA252 and 
TW20).
In the highly cytolytic strains, growth in 50% CS-TSB led to a significant decrease in toxin production in 
accordance with CS-mediated downregulation of Agr. We also observed significant differences in the degree of 
reduction of toxin production following growth in CS-TSB, whereby cytolytic activity was highly attenuated in 
JE2 and MW2 compared to EMRSA-15 and JKD6159 (Fig. 4A), reinforcing strain-dependent differences in S 
Figure 5. CS-mediated increased S aureus invasion and persistence within bronchial epithelial cells requires a 
functional Agr. CS promotes the invasion of S aureus strains harbouring a functional Agr system as observed 
by increased intracellular survival following (A) 2 h and (B) 24 h incubation when grown in 50% CS-TSB 
compared to 0% CS-TSB. Graphs represent the mean ± SD and significant differences measured using a two-
way ANOVA with Bonferroni’s multiple comparison test (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001).
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aureus response to CS exposure. CS exposure had no effect on toxicity in low cytolytic strains (MRSA252 and 
TW20). To confirm down regulation of toxin production following growth in 50% CS-TSB, we measured the 
expression of the major virulence factor, alpha haemolysin, by western blotting. Consistent with our toxicity 
results, highly cytolytic strains exhibited a marked reduction in alpha- haemolysin expression (Fig. 4B). Note that 
neither TW20 nor MRSA252 strains produced detectable alpha-haemolysin.
Next, we wanted to investigate whether this reduction in toxicity was a stable phenotype, resulting from muta-
tion following CS exposure, or a reversible characteristic following removal of CS. Here JE2 was grown in the 
presence and absence of 50% CS-TSB for 16 h, supernatants harvested and cytolytic activity assessed (Fig. 4C). 
Cell pellets from both 0% and 50% CS-TSB were washed thoroughly in PBS to remove residual CS components. 
0% CS-TSB cell pellet was resuspended in 0% CS-TSB whereas the cell pellet isolated from 50% CS-TSB was 
resuspended in either 0% CS-TSB or 50% CS-TSB. Cultures were then incubated and toxin production assessed 
at time 2, 4, 8, and 16 h post inoculation. No toxicity to either vesicles or bronchial epithelial cells was observed 
from supernatants isolated from time points 2–8 h (data not shown) under any conditions. However, cell pellets 
from 0% or 50% CS-TSB reintroduced to 0% CS-TSB resulted in toxin expression following 16 h growth, whereas 
significant attenuation in toxicity remained following growth in 50% CS-TSB (Fig. 4C), suggesting that CS atten-
uates toxin production in a reversible manner when the oxidative stress is lifted.
Figure 6. Growth in 50% CS-TSB increases the frequency of gentamicin resistant SCVs and mutation rate. S 
aureus strains were grown in the presence or absence of 50% CS-TSB for 16 h and (A) SCV frequency and (B) 
mutation rate were determined. (C) Colony morphology of WT (SH1000) and SCV isolated after growth in 
50% CS-TSB for 16 h (SCV 13). Colonies were sub-cultured onto TSA containing no antibiotics for 48 h. (D) 
Lack of carotenoid pigment and (E) haemolytic activity of the SCV is observed following growth on TSA agar 
or following incubation of 24 h SCV supernatant with human red blood cells. Addition of 1 µg ml−1 menadione 
restored pigment production and haemolytic activity suggesting defects in menaquinone production. (F) SCV 
frequency and (G) mutation rate in WT (SH1000) and in mutants of the SOS DNA mutagenic pathways (rexA; 
umuC; recA; rexB; dinB) in 0%, 25% and 50% CS-TSB were determined. Graphs represent the mean ± SD and 
significant differences measured either by using a two-way ANOVA with Bonferroni’s multiple comparison 
test (A,B,F,G) or a one-way ANOVA with Dunnett’s multiple comparison test (E) (*p < 0.05; **p < 0.01; 
***p < 0.001; ****p < 0.0001).
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CS-mediated increased S aureus invasion and short-term persistence within bronchial epithe-
lial cells requires a functional Agr. S aureus has the capacity to invade various cell types which affords 
the bacterium protection from immune surveillance and clearance from the majority of antibiotic therapies59. 
Previous studies concluded that Agr mutants have a higher invasive potential owing to their inability to down 
regulate surface proteins60. Given the effect of CS on Agr we wanted to investigate whether this effect translated 
into an increased invasive phenotype. Four strains which expressed high Agr activity when grown in 0% CS-TSB, 
(JKD6159, MW2, JE2 and EMRSA-15) all exhibited an increased invasive capacity as a result of growth in 50% 
CS-TSB following 2 h (Fig. 5A) and 24 h (Fig. 5B) post-infection as illustrated by higher intracellular colony 
forming units. Strain TW20 and MRSA252 showed no significance difference in invasion or persistence following 
growth in 50% CS-TSB. The Agr mutant (JE2 agrB::Tn) resulted in a 4-fold increase in invasion compared to the 
wild-type strain JE2. Exposure of the Agr mutant to CS resulted in no significant difference in initial invasion 
or following 24 h incubation compared to normal conditions, highlighting the importance of a functional Agr 
system in mediating CS-induced increased invasion.
Growth of S aureus in 50% CS-TSB increases both the frequency of gentamycin-resistant SCV 
and mutation frequency. Small colony variants (SCVs) of S aureus are a slow-growing, antibiotic-resistant, 
morphologically and phenotypically distinct sub-populations, central in long-term persistence within the host46. 
The exact triggers for SCV emergence are not fully understood but stressful conditions including antibiotic 
pressure61, nutrient limitation62 and chemical stresses generated by the host40 are known to induce SCV forma-
tion. Accordingly, we investigated whether CS exposure could trigger the emergence of SCVs. Following 16 h 
growth in 50% CS-TSB, all tested S aureus isolates bar MRSA252 exhibited a statistically significant increase in 













































































Figure 7. Short term CS exposure induces stable SCVs. (A) S aureus (SH1000) was incubated in 0% or 50% CS-
TSB and SCV frequency was assessed at 2, 4, 6, 8 and 16 h of growth. (B) Treatment of 50% CS-TSB with 12.5 
mM N-acetyl-L-cysteine significantly reduced the frequency of SCV. (C) The stability of SCVs isolated from 
growth in 0% CS-TSB or 50% CS-TSB was determined as outlined in Materials and Methods. Graphs represent 
the mean ± SD and significant differences measured either by using a two-way ANOVA with Bonferroni’s 
multiple comparison test (A,C) or a one-way ANOVA with Dunnett’s multiple comparison test (*p < 0.05; 
**p < 0.01; ***p < 0.001; ****p < 0.0001).
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the population frequency of gentamycin-resistant SCVs (Fig. 6A). To explore the basis for this, we determined 
the impact of CS exposure on the mutation frequency (Fig. 6B). Our results illustrate a significant or border sig-
nificant increase in the frequency of mutations in several different strains, confirming the mutagenic effect of CS 
exposure in S aureus. To characterise CS-induced SCVs, a randomly chosen isolate (SCV 13) was investigated for 
carotenoid pigment production and haemolysis (Fig. 6C–E). SCV13 had lower carotenoid pigment and haemo-
lytic activity compared to WT strain SH1000, a hallmark of S aureus SCVs46. Supplementation of SCV13 with 
menadione (1 µg ml−1) restored WT levels of carotenoid pigment and haemolytic activity, suggesting a mutation 
in the menadione biosynthetic genes, a pathway frequently defective in SCVs46,63. Whole genome sequencing 
of WT SH1000 and SCV13 confirmed a base deletion in the isochorismate synthase (menF) gene in SCV13, 
resulting in a frameshift and predicted premature stop codon at codon 144 of 403, abolishing the first step of 
menadione biosynthesis. Two single nucleotide polymorphisms (SNPs) were also discovered, both predicted to be 
non-synonymous SNPs in membrane transport proteins (SAUSA300_0852; mnhD and SAUSA300_1642; aapA). 
However, no role for these genes has been observed in SCV formation.
CS induced SCVs occur through DNA recombinational repair via the RexAB pathway. Recently, 
work by Painter et al. showed that exposure to sub-lethal concentrations of hydrogen peroxide induced SCV 
formation in S aureus via the SOS mutagenic DNA-repair pathway40. We therefore hypothesized that CS may 
activate the SOS response, resulting in elevated mutation rate and SCV emergence. To test this, we evaluated 
the SCV and mutational frequency in the presence and absence of CS-TSB in a set of mutants with transposon 
insertions in genes required for SOS induction and DNA repair in S aureus (Table 1; Fig. 6F,G); including recom-
binase A (SH1000recA::Tn), trans-lesion DNA polymerases IV and V (SH1000dinB::Tn and SH1000umuC::Tn 
respectively) and rexAB, genes involved in DNA recombinational repair (SH1000rexA::Tn and SH1000rexB::Tn 
respectively). We identified the RexAB pathway as essential in mediating the emergence of SCV following CS 
exposure. Disruption of the rexAB genes prevented emergence of both gentamicin SCVs and rifampicin mutants 
following growth in 25% CS-TSB compared to the wild-type SH1000 strain. In this case we compared the rexAB 
mutants and wildtype using 25% CS-TSB, as 50% CS-TSB resulted in total inhibition of growth of the rexAB 
mutants (Supplementary Fig. 1), suggesting that CS exposure results in double stranded DNA breaks in S aureus 
which is bactericidal in mutants of DNA recombinational repair.
Short-term CS exposure induces stable SCVs. Exposure times as little as 4 hours resulted in a signif-
icant increase in SCV frequency following growth in 50% CS-TSB, which continued at 6, 8 and 16 h of growth 
(Fig. 7A). In an effort to understand which class of chemicals was responsible SCV emergence we incubated 
50% CS-TSB with NAC for 16 h and compared SCV frequency values obtained from growth in TSB NAC and 
50% CS-TSB (Fig. 7B). Following NAC treatment of 50% CS-TSB, we observed a significant decrease in SCV 
frequency compared to growth in 50% CS-TSB. Additionally, we observed no significant difference in SCV fre-
quency when grown in TSB NAC and 50% CS-TSB NAC, highlighting that reactive oxygen species within CS 
constituent a major trigger for SCV emergence. The effects of purified nicotine and acrolein, key toxic compo-
nents in tobacco and cigarette smoke, on SCV emergence were also assessed however no significant difference in 
SCV frequency was observed (Supplementary Fig. 2).
SCVs are known to revert back to WT levels quite rapidly following removal of stressful conditions45. 
Therefore, we examined the stability of SCVs established with or without growth in 50% CS-TSB as previously 
described45. Significantly more colonies reverted back to wild-type when grown in TSB compared to growth in 
50% CS-TSB (Fig. 7C), illustrating that CS exposure results in significantly more stable SCVs.
Discussion
Smoking represents a major global health issue leading to enhanced risk of cancer and immune dysfunction. 
What is not clear is how smoking affects members of the human microbiome, in particular opportunistic path-
ogens such as S aureus. Here we detail the strain-dependent adaptation and virulence modulation of S aureus to 
CS exposure.
Studies investigating the risk of CS on S aureus colonisation are conflicting, with reports suggesting that smok-
ing can be considered a risk factor36,37,64,65, protective factor38,39,66 or having no association67,68 with S aureus prev-
alence. Using a panel of genetically distinct S aureus strains our data suggests that CA-MRSA strains were better 
able proliferate at high CS-TSB concentrations compared to HA-MRSA or common lab strains. Additionally, 
bacterial factors such as catalase, WTA and a functional recombinational repair pathway were shown to be vital 
for S aureus growth in CS-TSB. Furthermore, inhibition of reactive oxygen species permitted growth of suscepti-
ble S aureus strains to levels seen in the absence of CS. Our results suggest that both the degree of CS exposure and 
the genetic background of the colonising strain are important determinants in whether CS promotes or protects 
against S aureus colonisation. Interestingly, recent work showed that CA-MRSA strains produce significantly 
more WTA content than HA-MRSA or laboratory strains69, suggesting that WTA expression may be an impor-
tant factor in mediating resistance to CS-TSB and an important prerequisite for MRSA colonisation in smokers.
The Agr system is important in controlling the temporal expression of surface proteins and toxins and is cen-
tral in the ability of S aureus to form biofilms and invade and persist within host cells54. Kulkarni et al. have showed 
that Agr is affected at the transcriptional level, whereby agrC transcripts were significantly down-regulated fol-
lowing CS exposure27,29. Here, by using Agr mutants and experimentally determined high and low Agr active 
strains we confirm the importance of a functional Agr system in mediating enhanced biofilm formation and 
host cell invasiveness as a result of CS exposure. We illustrate that Agr mutants and isolates with low Agr activity 
remain unchanged in biofilm formation and invasiveness following exposure to CS, a feature that has not been 
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previously recognised. These results are noteworthy considering that Agr dysfunctional strains represent a signif-
icant proportion of clinical isolates70.
S aureus toxicity is central to virulence in many different animal models of infection71. Our results show that 
S aureus isolates with high Agr activity have reduced toxicity following CS exposure due to a reduced expression 
of Agr. Moreover, we found that the degree of reduction in cytolytic activity varies with different strains, whereby 
strains JE2 and MW2 were highly attenuated following growth in 50% CS-TSB compared to strains JKD6159 
and EMRSA-15, highlighting the strain dependent variation of virulence modulation imposed by CS exposure. 
Within the DNA-binding domain of AgrA, the transcriptional activator of the Agr system, exists two cysteine 
residues that, under oxidative conditions, form an intracellular disulphide bridge which results in the dissociation 
of AgrA from DNA, inhibiting agr activity72. In line with these observations we illustrate that S aureus toxicity is 
affected following CS exposure due to down regulation of Agr. Additionally, we show that this decrease in toxicity 
is not a permanent feature and if the oxidative stress is lifted toxicity can return to normal levels. Although tox-
icity is a significant feature in the virulence arsenal of S aureus, mounting evidence suggests the role of toxins to 
be disease-specific33,73, and in fact limiting toxin expression may be beneficial for progression of invasive diseases 
such as bacteraemia and may also contribute to intracellular persistence60,74.
S aureus can survive harsh conditions, either generated by the host (reactive oxygen species expressed by 
host immune cells) or by therapeutic antibiotic intervention, via several distinct mechanisms75, one of which is 
through the formation of SCVs40,62,76. Here, we report that CS triggers the emergence of SCVs in a cohort of gen-
otypically diverse and clinically relevant S aureus isolates. Furthermore, we highlight the mutagenic effect which 
CS imposes on S aureus and confirm by mutational analysis the role of the DNA recombinational repair pathway, 
RexAB, in mediating the accelerated mutation rate and subsequent increased SCV frequency. The RexAB path-
way is activated following double stranded (ds) DNA breaks and induction of this pathway has the capacity to 
accelerate the mutation rate through the formation of mutational hotspots77. As a result, we observed increased 
frequency of rifampicin resistance following CS exposure and speculate that resistance to other antibiotics, where 
resistance is determined by target site mutations such as for fluoroquinolones, is also likely to be affected. The 
exact effect of smoking on bacterial mutation rate and SCV emergence in vivo is unclear. Interestingly, recent 
work has shown that smoking induces the formation of ds DNA breaks in human cells in vivo78, providing cred-
ibility for our hypothesis that CS may induce similar DNA damage in S aureus and other bacteria habiting the 
nasopharynx, accelerating mutation rate, SCV emergence and antibiotic resistance.
We acknowledge that brief exposure to cigarette smoke in vitro is different to inhaled smoke over prolonged 
time periods. Nevertheless, previous groups have highlighted that in vitro CS exposure modulates virulence gene 
expression in S aureus and biofilm formation in respiratory and periodontal pathogens6,8,13. Taking these studies 
together we hypothesise that stressful conditions imposed by CS induces cellular stress responses in both host 
and microbial cells permitting adaptation to harsh conditions with the net effect of increasing virulence and/or 
potential for infection. Additionally, in certain diseases where smoking is a predominant risk factor in recalci-
trant infections such as chronic rhinosinusitis (CRS), the role S aureus SCVs in mediating this recurrence has 
been suggested. Two studies by Clement et al.79 and Tan et al.80, illustrated intracellular reservoirs containing S 
aureus SCVs derived from sinonasal specimens of CRS patients suggesting that the increased invasiveness and 
persistence linked to SCVs may play an important role in the recurrent nature of this pathology. It is tempting to 
speculate that smoking may play multiple roles in promoting CRS; disruption of mucociliary clearance mecha-
nisms of sinonasal epithelium, downregulation of local innate and adaptive immune responses and induction of 
SCVs, all favouring S aureus colonisation and subsequent re-infection.
Taken together our results highlight that CS redirects S aureus to a virulence profile associated with persis-
tent infection; that is increased biofilm formation, reduced toxicity, increased invasiveness, intracellular persis-
tence and SCV formation. However, we also demonstrate that specific virulence phenotypes vary among S aureus 
strains and care must be taken when extrapolating data on the effects of environmental stress and in vitro viru-
lence. As with previous work illustrating the link between CS and heightened bacterial virulence, we hope that 
our data will provide a further incentive for people not to smoke and for current smokers to quit.
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